New medication treatment options for bipolar disorders
Department of Psychiatry
Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Drug Tolerance; Humans
Mental and Social Health | Psychiatry | Psychiatry and Psychology
OBJECTIVE: To assess new treatment options for bipolar disorders.
METHOD: Controlled studies of new treatments for bipolar disorders were identified by computerized searches and reviews of scientific meeting proceedings, and were compiled by drug category.
RESULTS: Two main categories of medications, newer anticonvulsants and newer antipsychotics, are yielding emerging new treatment options for bipolar disorders. Newer anticonvulsants have diverse psychotropic profiles, and although not generally effective for acute mania, may have utility for other aspects of bipolar disorders (e.g. lamotrigine for maintenance or acute bipolar depression), or for comorbid conditions (e.g. gabapentin for anxiety or pain, topiramate for obesity, bulimia, alcohol dependence, or migraine, and zonisamide for obesity). In contrast, newer antipsychotics generally appear effective for acute mania, and some may ultimately prove effective in acute depression (e.g. olanzapine combined with fluoxetine, quetiapine) and maintenance (e.g. olanzapine).
CONCLUSION: Emerging research is yielding new treatment options for bipolar disorders and comorbid conditions.
DOI of Published Version
Acta Psychiatr Scand Suppl. 2004;(422):18-33. Link to article on publisher's site
Acta psychiatrica Scandinavica. Supplementum
Ketter TA, Wang PW, Nowakowska C, Marsh WK. (2004). New medication treatment options for bipolar disorders. Psychiatry Publications and Presentations. https://doi.org/10.1111/j.1600-0447.2004.00410.x. Retrieved from https://escholarship.umassmed.edu/psych_pp/581